Toggle Nav
Close
  • Menu
  • Setting

Anti-TNFSF13B/BAFF/CD257 Antibody (Belimumab)

Catalog No.
F1069
Anti-TNFSF13B/BAFF/CD257 Antibody (Belimumab)
Grouped product items
SizePriceStock Qty
100ug
Please inquire
Ship with 3-5 days
1mg
Please inquire
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Belimumab (LymphoStat B) is a humanized IgG1λ monoclonal antibody against the B lymphocyte stimulator (BLyS) protein. Belimumab antagonizes BLyS activity in autoimmune diseases and B lymphocyte malignancies. Belimumab can be used in systemic lupus erythematosus (SLE) research.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

144.54 kDa

Shipping

Dry ice

Cas No.

356547-88-1

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

Benlysta, LymphoStat-B, HGS1006

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

Q9Y275

Reactivity

Human, Cynomolgus

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Target

TNFSF13B / BAFF / CD257

Note

Please avoid freeze-thaw cycles.